Venom-derived peptides like melittin, mastoparan, and melectin can damage DNA directly or cause DNA lesions through oxidative stress, while some venom components show genoprotective effects — both properties relevant to potential therapeutic use.
Dual DNA effectsAnimal venom peptides can both damage and protect DNA — genotoxic properties must be assessed before any venom peptide becomes a medicine
What the researchers found
The review identifies two categories of DNA effects from venom-derived compounds:
**Genotoxic effects (DNA damage):**
- Venom peptides like mastoparan, melectin, and melittin (from bee and wasp venoms) can bind DNA and produce DNA breaks
- Crude venoms from jellyfish, scorpions, spiders, and snakes cause DNA damage primarily through cell membrane disruption and subsequent oxidative stress
- Sponge-derived compounds (avarol, variolin B) and sea squirt-derived trabectedin also bind and damage DNA
**Genoprotective effects:**
- Certain animal venoms or their components produce protective effects against DNA damage
- The dual nature (damage vs protection) depends on concentration, target cell type, and specific compound
Both properties have therapeutic relevance — DNA-damaging ability could be harnessed for anti-cancer drugs, while protective effects could aid in preventing mutations.
Why it matters
Venom-derived peptides are a major source of drug candidates — several are already in clinical use. But DNA damage is a serious safety concern that could cause mutations and cancer. This review highlights that genotoxicity testing must be a priority before venom peptides reach clinical use. At the same time, the DNA-damaging properties of certain venom peptides could be intentionally harnessed for cancer treatment, similar to how trabectedin (from sea squirts) is already used as an anti-cancer drug.
How the study worked
This is a narrative review synthesizing published research on the genotoxic and genoprotective effects of biologically active compounds derived from animal venoms. Sources include sponges, sea squirts, bees, wasps, jellyfish, scorpions, spiders, and snakes. The review examines both in vitro DNA-binding studies and cellular genotoxicity assays.
What this study cannot tell us
This is a narrative review with inherent selection bias. Many of the genotoxicity studies cited were performed in vitro under conditions that may not reflect physiological concentrations. The distinction between direct DNA damage and indirect oxidative damage is not always clear in the underlying studies. Most data comes from crude venoms rather than purified peptide components, making it difficult to attribute effects to specific peptides. The clinical relevance of the observed genotoxicity at therapeutic doses is largely unknown.
How to read the evidence
This is a narrative review synthesizing in vitro genotoxicity data from multiple sources. The underlying evidence is primarily from laboratory studies with varying methodologies. While the review raises important safety considerations, the clinical significance of the observed DNA effects at therapeutic doses remains unestablished.
When this study was published
Published in 2023, this review captures the current understanding of venom compound genotoxicity. As venom-derived drug development accelerates, the safety considerations highlighted here remain highly relevant.
The bigger picture
Venom-derived peptides represent one of nature's largest untapped pharmacological libraries. As drug development increasingly turns to these natural compounds, understanding their full biological profile — including effects on DNA that go beyond their primary targets — is essential for safe development. This review fills an important gap by systematically cataloging these 'hidden' effects that could make or break a venom peptide's path to becoming a medicine.
Questions still open
- At therapeutic concentrations, do venom-derived peptides like melittin cause clinically significant DNA damage?
- Could the genoprotective properties of certain venom components be developed into drugs that prevent DNA damage from radiation or chemotherapy?
- How can venom peptides be modified to retain their therapeutic activity while eliminating genotoxic potential?
Common questions
Are venom-based medicines safe if venom peptides can damage DNA?
Which venom peptides are already used as medicines?
Read the original research
A Review on Genotoxic and Genoprotective Effects of Biologically Active Compounds of Animal Origin.
Toxins, 15(2)
Citation
Sjakste, Nikolajs; Gajski, Goran. (2023). A Review on Genotoxic and Genoprotective Effects of Biologically Active Compounds of Animal Origin.. Toxins, 15(2). https://doi.org/10.3390/toxins15020165